Introduction:

chronic subdural hematoma is one of the most frequent neurosurgical pathologies.

Objective:

to describe the pathophysiology and current therapy of chronic subdural hematoma.

Methods:

a descriptive literature review on chronic subdural hematoma was carried out from March to April 2023. The SciELO, Scopus and PubMed databases were used. Fifteen articles were selected.

Results:

timely diagnosis and, above all, adequate therapy can greatly improve the prognosis of patients. The most frequent etiology is traumatic; however, some comorbidities and their treatments, such as anticoagulation, cannot be disregarded; situations that play an important role in favoring the formation of this pathology. Atorvastatin proved to be very useful in patients who do not require surgery soon.

Conclusions:

chronic subdural hematoma is a neurosurgical pathology of high frequency in the practice of general medicine and neurosurgery. There are two theories that explain the formation of chronic subdural hematomas. Surgery remains the management of choice; however, drugs such as statins, especially atorvastatin, are of great therapeutic value.

        · resumen en Español     · texto en Español     · Español ( pdf )